• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Lorillard Bonds Attractive Ahead of FDA Ruling

    Worries about the FDA's ruling on the relative safety of menthol cigarettes have left Lorillard's bonds looking attractively priced according to Morningstar's Dave Sekera.

  2. The Moat in Your Medicine Cabinet

    Aptar COO Steve Hagge on how the firm's close client relationships and FDA-approved dispensers give the firm an advantage in consumer packaging.

  3. Gen-Probe: New Tests Key to Increasing Revenue

    Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.

  4. No Shortage of Suitors for Genzyme

    Facing dwindling drug pipelines, plenty of big pharma firms may end up jumping into the bidding for Genzyme, according to Morningstar's Karen Andersen.

1
blog comments powered by Disqus
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.